Literature DB >> 28318026

Bone marrow fibrosis at diagnosis is associated with TP53 overexpression and adverse prognosis in low-risk myelodysplastic syndrome.

Fernando B Duarte1, Maritza C Barbosa2, Talyta E Jesus Dos Santos2, Romélia P G Lemes2, João P Vasconcelos3, Paulo R L de Vasconcelos4, Francisco D Rocha4, Ilana Zalcberg5, Diego F Coutinho5.   

Abstract

Entities:  

Keywords:  TP53; myelodysplastic syndrome; myelofibrosis; prognosis

Mesh：

Substances：

Year:  2017        PMID： 28318026     DOI： 10.1111/bjh.14656

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome.

Authors:  Youshan Zhao; Juan Guo; Sida Zhao; Roujia Wang; Lei Shi; Ying Fang; Zheng Zhang; Luxi Song; Dong Wu; Chunkang Chang
Journal:  Cancers (Basel)       Date:  2022-06-16       Impact factor: 6.575

2.  [Fibrosis-driving cells in patients with primary myelofibrosis and myelodysplastic syndromes with myelofibrosis].

Authors:  Y N Cai; P H Zhang; L H Fang; J Q Liu; B Li; Z F Xu; T J Qin; Z J Xiao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-12-14

Review 3.  TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings.

Authors:  Cosimo Cumbo; Giuseppina Tota; Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Francesco Albano
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.